Barrier Systems & Requirements for Sterile Manufacturing Annex … · 2020. 7. 13. · HEPA...

Preview:

Citation preview

Barrier Systems & Requirements

for Sterile Manufacturing –

Annex 1 Draft

Date : 14th July 2020

2

COPYRIGHT © PDA 2020

▪ Senior Consultant

Aseptic Processing & Containment @ SKAN AG

▪ PDA: Preventing Contamination and

Cross Contamination

▪ PDA Isolator Expert Group

▪ PDA Program Committee for the EU ATMP

and Bio Conference

▪ ISPE Chair CoP Containment and Chair Robotics

▪ ISPE CoP SPP Sterile Product Processing

▪ ISPE Chair Containment Guide

▪ PICs/Annex 2 – 2A ISPE Comments Team

▪ ISO TC 198 Aseptic Processing and Isolators

Your Presenter: Richard Denk

3

COPYRIGHT © PDA 2020

• Under Revision

• 6400 Comments back from the Industry.

• Complete new write of the document.

• Annex 1 is an European Document but with

global involvement.

Version 7 Publish Dec. 2017

Regulatory Annex 1 Draft 2017- 2020

4

COPYRIGHT © PDA 2020

• New Round of Comments to stakeholders

like ISPE, PDA to specific chapters.

• Lessons learned from the first draft.

Version 12 Draft Febr. 2020

Regulatory Annex 1 Draft 2017- 2020

5

PDA Points to Consider Published June 2020

COPYRIGHT © PDA 2020

6

COPYRIGHT © PDA 2020

• Contamination Control Strategy CCS

• Quality Risk Management QRM

• Keep Operators out of critical Aseptic

Operations

• Barrier Solutions the preferred technology.

What are the :major driver for the

new Annex 1

Regulatory Annex 1 Draft 2017- 2020

7

Conventional

Aseptic

Processing

Highest risk of

human

intervention

RABS «Restricted

Access Barrier

System»

Reduced risk of

human intervention

Isolators

Lowest risk of

human intervention

Regulatory Annex 1 Draft 2017- 2020

COPYRIGHT © PDA 2020

8

Conventional

Aseptic

Processing

Highest risk of

human

intervention

Conventional Solution

▪ Operator have access to critical areas

▪ No Barrier

▪ Contamination Risk on the Curtain.

▪ Intensive Training and Monitoring

▪ Technology should be replaced to Barrier Solutions.

Regulatory Annex 1 Draft 2017- 2020

COPYRIGHT © PDA 2020

9

RABS «Restricted

Access Barrier

System»

Reduced risk of

human intervention

RABS “ Restricted Access Barrier

System”

▪ Operator have access to critical areas

▪ Barrier but doors can be opened

▪ Decontamination inside of the door before closing.

▪ Intensive Training and Monitoring

▪ More and more poor designed RABS on the market.

Regulatory Annex 1 Draft 2017- 2020

COPYRIGHT © PDA 2020

10

Regulatory Annex 1 Draft 2017- 2020

COPYRIGHT © PDA 2020

11

Isolators

▪ Operator have no direct access to critical areas

▪ Surrounding Class C/D

▪ Validated and integrated decontamination system

with vH2O2

▪ Suitable for high potent products

RABS

▪ Operator have direct access to critical areas

▪ Surrounding Class B

▪ Decontamination together with the room

▪ Not suitable for high potent products

Regulatory Annex 1 Draft 2017- 2020

COPYRIGHT © PDA 2020

12

Isolators

Lowest risk of

human intervention

Isolators

▪ Operator have no direct access to critical areas

▪ Validated and accepted decontamination system

with

H2O2

▪ Reduced Clean Room requirements outside of the

Isolator (ISO 7/8 Class C/D)

▪ Less Gowning of the Operator

▪ More and more poor designed Isolators on the

market.

High risk to the product

Regulatory Annex 1 Draft 2017- 2020

COPYRIGHT © PDA 2020

13

COPYRIGHT © PDA 2020

The Olympic Rings for Annex1 Compliance in Isolators

Contamination Control Strategy

14

Contamination Control Strategy

COPYRIGHT © PDA 2020

15

Contamination Control Strategy

COPYRIGHT © PDA 2020

16

Stainless steel not polished Aluminium

Influence of Cleaning and Decontamination on different surfaces

Contamination Control Strategy

COPYRIGHT © PDA 2020

17

Contamination Control Strategy

COPYRIGHT © PDA 2020

18

Grade A - Air Supply and Surface Decontamination

Contamination Control Strategy

COPYRIGHT © PDA 2020

19

Contamination Control Strategy

COPYRIGHT © PDA 2020

20

Contamination Control Strategy

COPYRIGHT © PDA 2020

21

Contamination Control Strategy

COPYRIGHT © PDA 2020

22

Contamination Control Strategy

COPYRIGHT © PDA 2020

23

Service covers

Vaporizer plate for H2O2Intake air from air handling unit

Recirculation fan

Unidirectional air flow

Differential pressure indicator

HEPA filter

Diffusor membrane

Return air

through double door

RTP

Critical zone

“Classified working zone”

Critical Zone for Surface Decontamination

Contamination Control Strategy

COPYRIGHT © PDA 2020

24

dosing unit

vaporizer plate

Surface Decontamination

with vH2O2

Contamination Control Strategy

COPYRIGHT © PDA 2020

25

H2O2 SolutionFlash

Vaporizer

H2O2 vapour

Carrier gas

HEPA filter

Isolator chamber

Surface Decontamination

with vH2O2

Contamination Control Strategy

COPYRIGHT © PDA 2020

26

0 1 2 3 4

Leak Test Pre-Conditioning Conditioning Decontamination Aeration

Decontamination effect

Cycle phases

Surface Decontamination with vH2O2

Contamination Control Strategy

COPYRIGHT © PDA 2020

27

Fastest H2O2 cycles with state-of-the-art SKANFOG® decontamination

technology

▪ Micro-nebulization of H2O2

▪ Fastest decontamination process

27

Contamination Control Strategy

COPYRIGHT © PDA 2020

28

Cycle phases

Surface Decontamination with atomized H2O2

Contamination Control Strategy

COPYRIGHT © PDA 2020

29

Surface Decontamination with atomized H2O2

Contamination Control Strategy

COPYRIGHT © PDA 2020

30

Proof of Surface Decontamination with Biological Indicators

Contamination Control Strategy

COPYRIGHT © PDA 2020

31

• Defined test organism

• Defined initial population

• Carrier material

• Primary packaging

• Inactivation method

• e.g. Geobacillus

stearothermophilus

• e.g. 1.0 x 106 [spores/carrier]

• e.g. stainless steel

• e.g. Tyvek

• e.g. gaseous H2O2

Contamination Control Strategy

COPYRIGHT © PDA 2020

32

Worst Case Study with Biological Indicators

Contamination Control Strategy

COPYRIGHT © PDA 2020

33

Sterility Test

Contamination Control Strategy

COPYRIGHT © PDA 2020

34

Contamination Control Strategy

COPYRIGHT © PDA 2020

35

There will be a PDA Paper about Quality Risk Management for Isolator Gloves together with the BPOG.

Isolator Glove Test

Contamination Control Strategy

COPYRIGHT © PDA 2020

36

Visual Test Physical Test Glove Quality Risk Management

Contamination Control Strategy

COPYRIGHT © PDA 2020

37

Contamination Control Strategy

COPYRIGHT © PDA 2020

38

Contamination Control Strategy

COPYRIGHT © PDA 2020

39

COPYRIGHT © PDA 2020

GMP Cleaning and Operator SafetyContamination Control Strategy

40

Validation of the cleanliness of

non-product-contact surfaces

has increased in popularity

since the EMA proposed the

following measures in order to

demonstrate effective

management of the cross-

contamination risk (in Chapter

5.21 of Part 1 of its GMP

guidelines): “Depending on

the contamination risk,

verification of cleaning of non-

product contact surfaces and

monitoring of air within the

manufacturing area [...] in

order to demonstrate

effectiveness of control

measures against airborne

contamination or

contamination by mechanical

transfer.”

Contamination Control Strategy

COPYRIGHT © PDA 2020

41

Contamination Control Strategy

COPYRIGHT © PDA 2020

42

Contamination Control Strategy

COPYRIGHT © PDA 2020

43

Automation with Robotics

Contamination Control Strategy

COPYRIGHT © PDA 2020

44

Automation with Robotics

▪ Human intervention only possible with

the Robot

▪ New Requirements for Viable

Monitoring needed based on automation

and real time release.

▪ Automated Transfer of Stoppers, Caps

etc.

▪ Ready to Use (RTU) End to End design

( Sustainability)

▪ ISPE DACH SIG Robotic

Contamination Control Strategy

COPYRIGHT © PDA 2020

45

Questions?

Thank you!

richard.denk@skan.ch

COPYRIGHT © PDA 2020

COPYRIGHT © PDA 2020

Recommended